Doctors who don’t use MRI scans could be missing 85% of dangerous heart inflammation linked to COVID in student athletes, study finds
- Current strategies for finding myocarditis may be missing a 85 percent of cases, according to a study on Big 10 student athletes
- Researchers screened all athletes who contracted COVID-19 in the conference, finding 35 potential cases, normal methods would only have detected five
- Florida’s Keyontae Johnson is a high profile case of the condition, after he collapsed during a game last winter
- About 75 sudden deaths in athletes aged 13 to 25 occur every year because of the condition
Doctors who do not MRI scan all COVID-19 patients after infection could be missing 85 percent of myocarditis cases.
Researchers from 13 schools in the Big Ten athletic conferences performed Cardiovascular magnetic resonance imaging (CMR) on 1,597 student athletes that tested positive for the virus..
Screenings determined that 37 athletes had the inflammation known as myocarditis, with specifically nine student-athletes reporting clinical myocarditis, and 28 with subclinical myocarditis.
With standard testing based on only cardiac symptoms, only five of the cases would have been detected, meaning using CMR detected nearly 85 percent more cases.
The research shows that more people than expected may experience long-term COVID-19 symptoms, and that CMR testing may be necessary to truly catch all cases of the condition.
Cardiac MRIs caught 85% more cases of heart inflammation known as myocarditis rather than standard screenings. Florida guard Keyontae Johnson (pictured) became the most high profile case of myocarditis last year, when he collapsed during a game against Florida State
Myocarditis is a condition where a persons heart becomes inflamed and expands.
The inflammation may make the heart unable to pump blood properly, it can cause heart failure and sudden death in some cases.
People with the condition often suffer from shortness of breath, an abnormal heart beat and chest pain.
Screenings are usually carried out on those who report symptoms of the condition after having a viral infection, like COVID-19.
Researchers using CMR testing found that many student athletes who did not experience these symptoms are still at risk for developing clinical myocarditis.
Four different testing strategies were used, each with different levels of effectiveness.
The first strategy was the standard way to detect the condition, by performing CMR imaging testing on people who report cardiac symptoms.
Five cases were detected using the first strategy.
The second strategy, which detected 13 cases of myocarditis, used echocardiogram and troponin testing for all students who tested positive for COVID-19, and then performed CMR screenings on them.
The third strategy combined the first two strategies, and detected 17 cases.
The most effective strategy was performing CMR screenings on all who contracted COVID-19, finding the most cases and at least 10 that would not have been found with any of the previous methods.
All 28 student-athletes with subclinical myocarditis did not exhibit any symptoms beforehand, and would not have been screened for the condition in normal circumstances.
Performing this kind of testing on student athletes is especially important, according to researchers, since the condition is the leading cause of sudden death in athletes.
The Myocarditis Foundation reports that there are 75 sudden deaths from the condition every year from athletes aged 13 to 25, and almost all happen during or immediately after exercise.
A majority of myocarditis cases were found in student athletes who reported no symptoms of the condition, meaning many cases in the real world are likely going undetected
Florida Gators basketball guard Keyontae Johnson became a high profile case of the condition among student athletes last year.
Johnson collapsed on the court during a game against the rival Florida State Seminoles in December,
He had previously tested positive for COVID-19, and was thought to have made a full recovery.
After collapsing on the court, he was later diagnosed with acute myocarditis, though some doctors believe COVID-19 may not have been related to his diagnoses.
‘I could have died…You just can’t take life for granted,’ Johnson later told NBC.
Researchers hope that CMR testing can help prevent cases like Johnson’s, as myocarditis will be detected and treated before a player steps onto the court.
The full study will be available Thursday in the Journal of the American Medical Association.